|
DE19604919A1
(de)
|
1996-02-01 |
1997-08-07 |
Schering Ag |
Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
DE19604920A1
(de)
*
|
1996-02-01 |
1997-08-07 |
Schering Ag |
Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
US6635632B1
(en)
*
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
HU227128B1
(en)
*
|
1999-07-07 |
2010-07-28 |
Egyt Gyogyszervegyeszeti Gyar |
New 2,3-benzodiazepine derivatives
|
|
DE10004572A1
(de)
*
|
2000-02-02 |
2001-08-09 |
Boehringer Ingelheim Pharma |
Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2001096308A1
(en)
|
2000-06-12 |
2001-12-20 |
Eisai Co., Ltd. |
1,2-dihydropyridine compounds, process for preparation of the same and use thereof
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
HU225100B1
(hu)
*
|
2000-12-21 |
2006-06-28 |
Egyt Gyogyszervegyeszeti Gyar |
2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
|
|
US6649607B2
(en)
|
2001-05-18 |
2003-11-18 |
Vela Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing convulsions or seizures
|
|
JP2005503356A
(ja)
*
|
2001-06-07 |
2005-02-03 |
ニューロ３デー |
環状ヌクレオチドホスホジエステラーゼ阻害剤、その製造および使用
|
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
|
US6864251B2
(en)
*
|
2002-12-03 |
2005-03-08 |
Vela Pharmaceuticals, Inc. |
Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
|
|
US6638928B1
(en)
|
2002-12-03 |
2003-10-28 |
Vela Pharmaceuticals, Inc. |
Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
|
|
US7745431B2
(en)
*
|
2002-12-03 |
2010-06-29 |
Vela Acquisition Corporation |
Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof
|
|
US7022700B2
(en)
*
|
2002-12-03 |
2006-04-04 |
Vela Pharmaceuticals, Inc. |
Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
|
|
WO2004069155A2
(en)
*
|
2002-12-03 |
2004-08-19 |
Vela Pharmaceuticals, Inc. |
Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
|
|
PL378366A1
(pl)
|
2003-01-13 |
2006-04-03 |
Cortex Pharmaceuticals, Inc. |
Sposób leczenia osłabienia funkcji poznawczych spowodowanego deprywacją snu i stresem
|
|
US20040152694A1
(en)
*
|
2003-02-04 |
2004-08-05 |
Istvan Kurucz |
Methods and compositions for treating inflammatory disorders of the airways
|
|
US20040224943A1
(en)
*
|
2003-02-19 |
2004-11-11 |
Leventer Steven M. |
Method of lowering body temperature with (R) - 2,3-benzodiazepines
|
|
US20040162284A1
(en)
*
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
|
GB0325175D0
(en)
*
|
2003-10-28 |
2003-12-03 |
Novartis Ag |
Organic compounds
|
|
MY148809A
(en)
|
2004-07-06 |
2013-05-31 |
Eisai R&D Man Co Ltd |
Crystals of 1,2-dihydropyridine compound and their production process
|
|
JP2007153755A
(ja)
*
|
2005-12-01 |
2007-06-21 |
Gifu Univ |
プロリン類縁体
|
|
EP2338492A1
(en)
|
2009-12-24 |
2011-06-29 |
Universidad del Pais Vasco |
Methods and compositions for the treatment of alzheimer
|
|
FR2972454B1
(fr)
*
|
2011-03-08 |
2013-03-01 |
Servier Lab |
Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP6333251B2
(ja)
|
2012-08-16 |
2018-05-30 |
バイエル ファーマ アクチエンゲゼルシャフト |
２，３−ベンゾジアゼピン類
|
|
CA2901352A1
(en)
|
2013-02-19 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
|
|
CA2901805A1
(en)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
4-substituted pyrrolo- and pyrazolo-diazepines
|
|
HK1212972A1
(zh)
|
2013-02-22 |
2016-06-24 |
Bayer Pharma Aktiengesellschaft |
作爲bet-蛋白抑制剂用於治疗过度增殖性疾病的吡咯并-和吡唑并-三唑并二氮杂卓
|
|
EP3311842A1
(en)
|
2013-06-13 |
2018-04-25 |
VeroScience LLC |
Compositions and methods for treating metabolic disorders
|
|
EP3436021B1
(en)
|
2016-03-29 |
2026-07-29 |
RespireRx Pharmaceuticals, Inc. |
Compositions comprising low impact ampakines for treating attention deficit disorders
|
|
WO2020124090A1
(en)
|
2018-12-14 |
2020-06-18 |
Eisai R&D Management Co., Ltd. |
Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds
|